Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on April 30, 2020, reporting its financial results for the quarter ended March 31, 2020. The primary focus of this filing is the release of the company's earnings and provides investor access to the accompanying press release (Exhibit 99.1) which details both GAAP and non-GAAP financial measures. Investors should note that the company emphasizes the usefulness of non-GAAP measures for internal operational and financial planning, and advises their consideration alongside GAAP figures. A reconciliation of these measures is available within the press release, which is crucial for a comprehensive understanding of Gilead's financial performance during the first quarter of 2020. The filing also includes standard interactive data files.
Key Highlights
- 1Gilead Sciences announced its first-quarter 2020 financial results on April 30, 2020.
- 2The 8-K filing primarily serves to furnish the earnings press release (Exhibit 99.1) to the SEC.
- 3The press release contains detailed financial information prepared under both U.S. GAAP and non-GAAP measures.
- 4Gilead's management utilizes non-GAAP financial information for internal operational and financial planning purposes.
- 5Investors are advised to review the non-GAAP information in conjunction with, and not as a substitute for, GAAP financial statements.
- 6A reconciliation between GAAP and non-GAAP financial measures is provided in the press release.
- 7The filing includes the cover page interactive data file.